Skip to main content
ASTAL LABORATORIES LIMITED logo

ASTAL LABORATORIES LIMITED — Investor Relations & Filings

Ticker · 512600 ISIN · INE307N01014 LEI · 8945004HO2WCBQ0CJ976 BSE.NS Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2023-07-21 Major Shareholding Noti…
Country IN India
Listing BSE.NS 512600

About ASTAL LABORATORIES LIMITED

https://miel.co.in/

Astal Laboratories Limited is a pharmaceutical organization engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company's product portfolio encompasses various dosage forms, including tablets, capsules, liquid orals, and topical preparations. It operates across several therapeutic categories, such as anti-infectives, analgesics, and gastrointestinal treatments. Astal Laboratories prioritizes quality control and adheres to established manufacturing standards to ensure the safety and efficacy of its products. The company focuses on providing accessible healthcare solutions through a robust distribution network and a commitment to research-driven formulation development.

Recent filings

Filing Released Lang Actions
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aceso Research Labs LLP
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the acquisition of shares by ACESO RESEARCH LABS LLP, a promoter of Macro International Limited, including shareholding percentages before and after the acquisition, mode and date of acquisition, and related compliance information. This type of filing is a notification of a change in significant share ownership levels, specifically a substantial acquisition of shares. It is not a financial report, earnings release, or management report, nor is it an announcement of a meeting or voting results. The document fits the definition of a Major Shareholding Notification (MRQ). The document length and content confirm it is the actual disclosure, not just an announcement of a report publication or a regulatory filing of a different nature.
2023-07-21 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aceso Research Labs LLP
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the acquisition of shares by ACESO RESEARCH LABS LLP in MACRO INTERNATIONAL LIMITED, including shareholding percentages before and after the acquisition, mode of acquisition, and dates. This type of filing is a notification of a major shareholding change, specifically a substantial acquisition of shares. It is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding changes. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length and content confirm it is not a brief announcement but a formal disclosure under SEBI regulations.
2023-07-21 English
News Paper Publication of the extract of unaudited financial results for the quarter ended 30th June 2023.
Regulatory Filings
2023-07-17 English
the board has considered and approved the resignation of CEO.
Regulatory Filings
2023-07-15 English
the board has considered and approved the resignation of CFO.
Regulatory Filings
2023-07-15 English
the board has approved the appointment of Chief Financial officer.
Regulatory Filings
2023-07-15 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.